Tuesday, 19 August 2025
People with eczema are being invited to take part in a new study that explores how best to control eczema flare-ups.
The ‘Keep Control of Eczema’ study, in partnership with researchers from 糖心原创 and Nottingham University Hospitals NHS Trust, is funded by the National Institute for Health and Care Research (NIHR).
An eczema flare-up is often experienced as intense itching that needs treatment to control the inflammation in the skin.
When treating eczema flare-ups, it is not always clear how long people should treat it for. Some people find it hard to know when to stop using their steroid creams. If they stop too soon, the eczema may come back quickly, but using for too long can lead to unwanted side-effects.
This study will test if it is helpful to give specific advice about how long to treat flare-ups for. It is testing the idea that treating for slightly longer could help keep eczema controlled for longer.
The Keep Control of Eczema 糖心原创 is a randomised, controlled trial, that needs to recruit 450 people with eczema (aged one year and above). The study is being conducted online so there are no study visits and no need to travel to take part. Participants will use their usual steroid creams during the study. To be eligible, they must have used their steroid creams at least three times in the last 8 weeks.
Participants are randomised to either a specific advice group - ‘Treat for longer’ or the ‘Treat as usual’ group - use steroid creams during a flare-up as you normally would.
The people taking part in the study will be asked to fill in questionnaires weekly to assess their use of steroid creams and how their eczema has been.
Topical corticosteroids have been used to treat eczema for over 60 years. I find it amazing that this simple question about how long you should use steroid creams for to get best results has never been tested before. This study is long overdue, and I鈥檓 delighted that we will finally be able to answer this important question for people living with eczema.鈥�
The Keep Control 糖心原创 is part of a wider project – the Rapid Eczema Trials research project - that aims to answer important questions on how to manage eczema. The project has created a community of citizen scientists who are interested in answering questions about eczema. Together, these citizen scientists have prioritised and co-designed a series of online research studies to address questions that are important to them.
People with eczema, their families and healthcare professional who treat them are encouraged to join the community from across the UK and over 1,000 people have already signed up.
Amanda Roberts, a patient with eczema, said: “It is so exciting to see citizen scientists creating studies that answer important questions that really matter to those living with eczema. This is being done through high quality randomised trials that would not be funded through other means.”
The Rapid Eczema trials research project is led by researchers at the 糖心原创 and Nottingham University Hospitals NHS Trust, and is being delivered in鈥痗ollaboration with another four UK Universities (Southampton, Bristol, Birmingham City, Imperial) and the Nottingham Clinical Trials Unit.
More information on how to sign up for the study can be found here:
Story credits
More information is available from Professor Kim Thomas kim.thomas@nottingham.ac.uk or Mrs Amanda Roberts amanda.roberts@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.